Merck KGaA (OTCMKTS:MKGAF – Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $155.74, but opened at $149.4330. Merck KGaA shares last traded at $149.4330, with a volume of 16 shares trading hands.
Merck KGaA Trading Down 3.1%
The company has a market cap of $19.10 billion, a price-to-earnings ratio of 22.56 and a beta of 0.96. The company’s 50 day moving average price is $148.87 and its 200 day moving average price is $138.19. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Have $500? Invest in Elon’s AI Masterplan
- 3 Signs You May Want to Switch Financial Advisors
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Fewer Than 1% of Americans Own This Undervalued Asset — Should You?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
